Found: 1
Select item for more details and to access through your institution.
Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2008, v. 23, n. 3, p. 211, doi. 10.1002/hup.921
- By:
- Publication type:
- Article